Purus Wealth Management LLC increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 0.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 25,315 shares of the medical equipment provider’s stock after buying an additional 23 shares during the period. Intuitive Surgical comprises approximately 5.3% of Purus Wealth Management LLC’s holdings, making the stock its 3rd biggest holding. Purus Wealth Management LLC’s holdings in Intuitive Surgical were worth $12,538,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also made changes to their positions in ISRG. Parvin Asset Management LLC acquired a new position in Intuitive Surgical during the 4th quarter valued at about $26,000. Chilton Capital Management LLC boosted its stake in shares of Intuitive Surgical by 614.3% during the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 43 shares in the last quarter. Global Financial Private Client LLC increased its stake in Intuitive Surgical by 253.3% in the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider’s stock worth $26,000 after purchasing an additional 38 shares in the last quarter. Elite Financial Inc. purchased a new stake in shares of Intuitive Surgical in the 1st quarter valued at approximately $26,000. Finally, LFA Lugano Financial Advisors SA purchased a new position in shares of Intuitive Surgical during the first quarter valued at $30,000. Institutional investors own 83.64% of the company’s stock.
Intuitive Surgical Stock Down 2.2%
Shares of NASDAQ:ISRG opened at $469.88 on Friday. The company has a market cap of $168.44 billion, a price-to-earnings ratio of 65.53, a PEG ratio of 5.04 and a beta of 1.59. The business has a 50 day moving average price of $505.14 and a 200 day moving average price of $522.78. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00.
Wall Street Analysts Forecast Growth
A number of research firms recently commented on ISRG. Deutsche Bank Aktiengesellschaft downgraded Intuitive Surgical from a “hold” rating to a “sell” rating and dropped their price objective for the stock from $515.00 to $440.00 in a report on Monday, June 9th. Erste Group Bank restated a “hold” rating on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Citigroup reaffirmed a “buy” rating and issued a $650.00 price objective (up previously from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. Zacks Research downgraded shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Wednesday. Finally, Truist Financial raised their target price on Intuitive Surgical from $590.00 to $600.00 and gave the company a “buy” rating in a report on Wednesday, July 23rd. Thirteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $595.95.
Read Our Latest Stock Analysis on Intuitive Surgical
Insiders Place Their Bets
In other news, EVP Myriam Curet sold 4,500 shares of the company’s stock in a transaction dated Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the completion of the transaction, the executive vice president owned 353 shares of the company’s stock, valued at approximately $173,845.44. This represents a 92.73% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Mark Brosius sold 216 shares of Intuitive Surgical stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $563.11, for a total value of $121,631.76. Following the sale, the senior vice president directly owned 907 shares in the company, valued at approximately $510,740.77. This trade represents a 19.23% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 15,839 shares of company stock worth $7,896,972 in the last ninety days. Insiders own 0.70% of the company’s stock.
Intuitive Surgical Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
See Also
- Five stocks we like better than Intuitive Surgical
- Growth Stocks: What They Are, Examples and How to Invest
- Can Identity Security Fuel CrowdStrike’s Next Growth Phase?
- How to start investing in penny stocks
- Broadcom Named in Apple’s $100B U.S. Investment Plan
- Bank Stocks – Best Bank Stocks to Invest In
- 3 Reasons Salesforce Is a Bargain Right Now
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.